Baxter reports fourth-quarter and full-year 2022 results

Deerfield, ill.--(business wire)--baxter international inc. (nyse:bax), a global medtech leader, today reported results for the fourth quarter and full year ended dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023. “baxter employees worldwide are embracing the power of our lifesaving mission to navigate a complex healthcare landscape and respond to sustained demand for our essential products,” said josÉ (joe) e.
BAX Ratings Summary
BAX Quant Ranking